1. Soliyev A.U. /Qari va keksalarda arterial gipertoniya tarqalishi va xavf omillarining uchrashi. //Biomeditsina va amaliyot jurnali. B.435-441. Maxsus son. 2020 yil. Toshkent. 2. Degirolamo C., Sabbà C., Moschetta A. Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23 (англ.) // Nat. Rev. Drug Discov.. - 2016. — Vol. 15. — P. 51—69. — doi:10.1038/nrd.2015.9. 3. Armelin H. A. Pituitary extracts and steroid hormones in the control of 3T3 cell growth (англ.) // Proceedings of the National Academy of Sciences of the United States of America : journal. — 1973. — September (vol. 70, no. 9). — P. 2702—2706. — doi:10.1073/pnas.70.9.2702. — Bibcode: 1973PNAS...70.2702A. — PMID 4354860. 4. https://www.ncbi.nlm.nih.gov/pubmed/20581332, Zechel S, Werner S, Unsicker K, von Bohlen und Halbach O. 2010. Expression and functions of fibroblast growth factor 2 (FGF-2) in hippocampal formation. Neuroscientist 16: 357—373. 5. Staiger H, Keuper M, Berti L et al. Fibroblast growth factor 21-metabolic role in mice and men. Endocrine Rev 2017; 38 (5): 468–88. DOI: 10.1210/er.2017. 6. Choi JR et al. Serum fibroblast growth factor 21 and new-onset metabolic syndrome: KoGES-ARIRANG study. Yonsei Med J 2018; 59 (2): 287–93. DOI: 10.3349/ymj.2018.59.2.287 7. Bobbert T et al. Fibroblast growth factor 21 predicts the metabolic syndrome and type 2 diabetes in Caucasians. Diabetes Care 2013; 36 (1): 145–9. DOI: 10.2337/dc12-0703 8. Chen C et al. High plasma level of fibroblast growth factor 21 is an independent predictor of type 2 diabetes: A 5.4-year population-based prospective study in Chinese subjects. Diabetes Care 2011; 34 (9): 2113–5. DOI: 10.2337/dc11-0294